| pubmed-article:2935417 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2935417 | lifeskim:mentions | umls-concept:C0003315 | lld:lifeskim |
| pubmed-article:2935417 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:2935417 | lifeskim:mentions | umls-concept:C0023820 | lld:lifeskim |
| pubmed-article:2935417 | lifeskim:mentions | umls-concept:C0024262 | lld:lifeskim |
| pubmed-article:2935417 | lifeskim:mentions | umls-concept:C0007613 | lld:lifeskim |
| pubmed-article:2935417 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2935417 | pubmed:dateCreated | 1986-3-24 | lld:pubmed |
| pubmed-article:2935417 | pubmed:abstractText | The low density classes of plasma lipoproteins (d less than or equal to 1.063 g/ml) suppress mitogenic activation and proliferation of peripheral blood T lymphocytes. Here we demonstrate that lipoprotein suppression can be directed against the accessory cells (greater than 85% monocytes) required for optimal activation of lymphocytes by polyclonal mitogens. Preincubation of accessory cells for 24 h with very low (VLDL) and low (LDL) density lipoproteins suppressed their ability to enhance lymphocyte activation, whereas preincubation of T lymphocytes with lipoproteins did not alter their responsiveness to mitogens. The phenotypic distribution of the accessory cell population was not specifically altered by the lipoproteins, nor did loss of viability account for the suppressive effect of the lipoproteins. Furthermore, the lipoprotein-preincubated accessory cells did not secrete stable inhibitory substances, nor was their ability to produce interleukin 1 diminished. The results of mixing experiments indicate that VLDL-incubated accessory cells had not differentiated into suppressor cells. The lipoprotein-incubated accessory cells appeared to induce the interleukin 2-responsive state in the mitogen-activated lymphocytes, but could not deliver a signal or signals required for the further progression of the activated lymphocytes through the cell cycle. These important findings define at least two types of accessory cell function in the in vitro activation of T lymphocytes. | lld:pubmed |
| pubmed-article:2935417 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2935417 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2935417 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2935417 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2935417 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:2935417 | pubmed:issn | 0014-4827 | lld:pubmed |
| pubmed-article:2935417 | pubmed:author | pubmed-author:OkanoYY | lld:pubmed |
| pubmed-article:2935417 | pubmed:author | pubmed-author:NakayasuTT | lld:pubmed |
| pubmed-article:2935417 | pubmed:author | pubmed-author:HarmonyJ AJA | lld:pubmed |
| pubmed-article:2935417 | pubmed:author | pubmed-author:PAULM BMB | lld:pubmed |
| pubmed-article:2935417 | pubmed:author | pubmed-author:McCarthyB MBM | lld:pubmed |
| pubmed-article:2935417 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2935417 | pubmed:volume | 163 | lld:pubmed |
| pubmed-article:2935417 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2935417 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2935417 | pubmed:pagination | 103-16 | lld:pubmed |
| pubmed-article:2935417 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:meshHeading | pubmed-meshheading:2935417-... | lld:pubmed |
| pubmed-article:2935417 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:2935417 | pubmed:articleTitle | Plasma lipoproteins can suppress accessory cell function and consequently suppress lymphocyte activation. | lld:pubmed |
| pubmed-article:2935417 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2935417 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2935417 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2935417 | lld:pubmed |
